iifl-logo

Dipna Pharmachem Ltd Board Meeting

Add as a Preferred Source on Google
5.76
(-8.86%)
Jul 10, 2026|09:31:00 PM

Dipna Pharmachem CORPORATE ACTIONS

12/07/2025calendar-icon
12/07/2026calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting2 Jul 202627 Jun 2026
Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/07/2026 inter alia to consider and approve Intimation of Board Meeting to be held on Wednesday 1st July 2026 Dipna Pharmachem Ltd informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/07/2026 ,inter alia, to consider and approve Outcome and Intimation for Rescheduling of Board Meeting to 2nd July, 2026 Outcome and Intimation for Rescheduling of Board Meeting to 2nd July, 2026 (As per BSE Announcement dated on: 01.07.2026) Outcome of Board Meeting held today i.e. 2nd July, 2026 (As per BSE Announcement dated on: 02.07.2026)
Board Meeting11 May 20262 Jul 2026
Outcome and Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Board Meeting22 Apr 202622 Apr 2026
Outcome of the Board meeting and Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Board Meeting29 Nov 202529 Nov 2025
Board of Directors, at its meeting held on today, consider and allotted 22,44,000 Equity Shares pursuant to the conversion of warrants the 22,44,000 convertible warrants (out of a total 5,80,32,500 convertible warrants) to the allottee(s) belonging to the Non-promoter category.
Board Meeting26 Nov 202510 Nov 2025
Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve Intimation of Board Meeting to be held on Friday 14th November 2025 Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/11/2025 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company which was scheduled to be held on 14th November, 2025 at 4:30 P.M. has been rescheduled due to unavoidable circumstances, to Wednesday , 19th November, 2025 at 4:30 P. M. at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad - 380 055, inter alia to consider and approve: 1. The Unaudited Financial Results of the Company for the Half Year ended on 30th September, 2025 along with Limited Review Report. 2. Any other matter to be discussed and consider with the permission of Chairperson of the Board Meeting. (As Per BSE Announcement Dated on: 14.11.2025) Intimation of Rescheduling of Board Meeting (As per BSE Announcement dated on: 19.11.2025) Outcome of Board Meeting held today i.e. Wednesday, 26th November, 2025 Unaudited Financial Results For the Half year ended on 30th September, 2025. (As Per BSE Announcement Dated on:26.11.2025)
Board Meeting9 Sep 20259 Sep 2025
Allotment of 2,98,74,000 Convertible Warrants pursuant to the preferential issue.
Board Meeting8 Aug 202513 Aug 2025
Outcome of the Board Meeting held on 08-08-2025 Outcome of Board Meeting held on 8th August, 2025

Dipna Pharmachem: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.